CMBA
VIVO

C.M. Bidwell & Associates’s Meridian Bioscience Inc VIVO Stock Holding History

C.M. Bidwell & Associates’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,125
Closed -$82K – 635
2021
Q1 		$82K Buy
+3,125
New +$74.3K 0.06% 258

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

C.M. Bidwell & Associates's VIVO Position: Q2 2021 in Review

C.M. Bidwell & Associates sold out of Meridian Bioscience Inc (VIVO) in Q2 2021, closing a stake of 3,125 shares — an estimated $82K sold.

C.M. Bidwell & Associates first reported a position in VIVO in Q1 2021 and held it in 1 quarter. The position peaked at $82K in Q1 2021. 189 funds tracked by Wall St. Rank hold VIVO as of Q2 2021.

  • C.M. Bidwell & Associates reported no remaining Meridian Bioscience Inc position as of Q2 2021 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 3,125 Meridian Bioscience Inc shares in Q2 2021, an estimated $82K.
  • C.M. Bidwell & Associates first reported a position in Meridian Bioscience Inc in Q1 2021 and held it in 1 quarter.
  • C.M. Bidwell & Associates's Meridian Bioscience Inc position peaked at $82K in Q1 2021.
  • 189 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2021.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2021, filed 13 Aug 2021.